Esp36 Inhibitors
Esp36 inhibitors represent a class of chemical compounds that specifically target and inhibit the activity of the Esp36 protein, a factor associated with certain cellular processes in various organisms. Esp36 is often implicated in signaling pathways or structural functions within the cell, making it a pivotal component of certain biological mechanisms. The inhibitors of Esp36 are designed to bind selectively to this protein, disrupting its normal function. This binding can occur through different mechanisms, such as competitive inhibition, where the inhibitor competes with the natural substrate of Esp36 for binding sites, or through allosteric inhibition, where the inhibitor binds to a different site on the protein, inducing conformational changes that reduce its activity. These inhibitors are often identified and optimized through extensive research, including structure-activity relationship (SAR) studies, which help to refine the molecular structures for enhanced efficacy and selectivity.
The chemical structures of Esp36 inhibitors are diverse, reflecting the variety of approaches used to target this protein. Some inhibitors may be small organic molecules designed to penetrate cellular membranes and interact with intracellular Esp36, while others might be larger, more complex molecules that rely on precise docking to the protein's active site. The design of these inhibitors often involves the use of computational modeling and screening techniques to predict how different molecules will interact with Esp36. In addition, the development of these inhibitors requires a deep understanding of the protein's structure, including its binding sites, conformational flexibility, and the dynamics of its interaction with other cellular components. The end goal in the synthesis and refinement of Esp36 inhibitors is to achieve a molecule with high affinity and specificity for the target protein, ensuring that it can effectively modulate Esp36 activity under various experimental conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A-769662 is an AMP-activated protein kinase (AMPK) activator. By stimulating AMPK, A-769662 can potentially activate Esp36 by modulating cellular energy homeostasis and influencing downstream processes associated with AMPK activation, contributing to Esp36 activation. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GW501516, also known as Cardarine, is a peroxisome proliferator-activated receptor-delta (PPAR-δ) agonist. It may activate Esp36 by binding to PPAR-δ, leading to the modulation of gene expression and cellular processes associated with Esp36 activation. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone is a thiazolidinedione and a selective agonist for peroxisome proliferator-activated receptor-gamma (PPAR-γ). Activation of PPAR-γ by rosiglitazone can potentially modulate Esp36 activity through the regulation of gene expression and cellular processes associated with PPAR-γ activation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of mitogen-activated protein kinase kinase (MEK). Inhibition of MEK may activate Esp36 by preventing its phosphorylation and modulating downstream signaling pathways. This impact on intracellular signaling cascades can contribute to Esp36 activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 mitogen-activated protein kinase (MAPK). Inhibition of p38 MAPK may activate Esp36 by preventing its phosphorylation and modulating downstream signaling pathways. This modulation of intracellular signaling cascades can contribute to Esp36 activation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of Rho-associated protein kinase (ROCK). Inhibition of ROCK may activate Esp36 by modulating Rho GTPase signaling and downstream processes. This influence on intracellular signaling cascades can contribute to Esp36 activation. | ||||||
GSK 650394 | 890842-28-1 | sc-361201 sc-361201A | 10 mg 50 mg | $187.00 $769.00 | 8 | |
GSK-650394 is a selective inhibitor of p38α MAPK. Inhibition of p38α MAPK may activate Esp36 by preventing its phosphorylation and modulating downstream signaling pathways. This influence on intracellular signaling cascades can contribute to Esp36 activation. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide) is an AMP-activated protein kinase (AMPK) activator. It can activate Esp36 by stimulating AMPK, leading to the modulation of cellular energy homeostasis and influencing downstream processes associated with AMPK activation. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Bay 11-7082 is an inhibitor of nuclear factor-kappa B (NF-κB) activation. Inhibition of NF-κB may activate Esp36 by preventing its regulation through NF-κB signaling pathways. The impact on NF-κB-related cellular processes can contribute to Esp36 activation. | ||||||